As neuroinflammation seems an early event of AD and is linked to many pathways involved in AD pathogenesis, treating neuroinflammation with TNF-α inhibitors may be a viable way of preventing or slowing AD progression. The gene discussed is TNF; the disease is Alzheimer disease.